Mutant huntingtin enhances excitotoxic cell death

Molecular and Cellular Neuroscience

Volumn 17, Issue 1, 2001, Pages 41-53

  Zeron, Melinda M ^a   Chen, Nansheng ^a   Moshaver, Ali ^a   Ting Chun Lee, Allen ^a   Wellington, Cheryl L ^a   Hayden, Michael R ^a   Raymond, Lynn A ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE RECEPTOR; HUNTINGTIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; POLYGLUTAMINE; RECEPTOR SUBTYPE;

APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUNTINGTON CHOREA; NEOSTRIATUM; NERVE DEGENERATION; NEUROTOXICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

SPINY;

EID: 0035154912     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1006/mcne.2000.0909     Document Type: Article

References (72)

1. Abnormalities of striatal projection neurons and N-methyl-D-aspartate receptors in presymptomatic Huntington's disease
2. Alternative excitotoxic hypotheses
3. Transfection of N-methyl-D-aspartate receptors in a nonneuronal cell line leads to cell death
4. Glutamate-induced neuronal death: A succession of necrosis or apoptosis depending on mitochondrial function
5. Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid
6. Quinolinic acid striatal lesions in primates as a model of Huntington's disease
7. Pharmacological properties of acquired excitotoxicity in Chinese hamster ovary cells transfected with N-methyl-D-aspartate receptor subunits
8. Apoptosis and necrosis: Two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures
9. Differential sensitivity of recombinant N-methyl-D-aspartate receptor subtypes to zinc inhibition
10. Subtype-specific enhancement of NMDA receptor currents by mutant huntingtin
11. Subtype-dependence of NMDA receptor channel open probability
12. Ischemia-induced neuronal apoptosis
13. Optimal expression of cloned NMDAR1/NMDAR2A heteromeric glutamate receptors: A biochemical characterization
14. Expession of NMDAR1-1a (N598Q)/NMDAR2A receptors results in decreased cell mortality
15. Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture
16. Oxidative stress, glutamate, and neurodegenerative disorders
17. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation
18. Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington's disease
19. Excitotoxic injury of the neostriatum: A model for Huntington's disease
20. Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons
21. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain
22. The glutamate receptor ion channels
23. Splice variant-specific interaction of the NMDA receptor subunit NR1 with neuronal intermediate filaments
24. Selective sparing of a class of striatal neurons in Huntington's disease
25. Cellular localization of hutingtin in striatal and cortical neurons in rats: Lack of correlation with neuronal vulnerability in Huntington's disease
26. Multiplicity of glutamate receptor subunits in single striatal neurons: An RNA amplification study
27. Absence of disease phenotype and intergenerational stability of the CAG repeat in transgenic mice expressing the human Huntington disease transcript
28. Calcium ionophores can induce either apoptosis or necrosis in cultured cortical neurons
29. The influence of huntingtin protein size on nuclear localization and cellular toxicity
30. Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity
31. A primate model of Huntington's disease: Behavioral and anatomical studies of unilateral excitotoxic lesions of the caudate-putamen in the baboon
32. A YAC transgenic mouse model for Huntington disease: Expression of full-length mutant huntingtin demonstrates initial cytoplasmic toxicity followed by a neurological phenotype and selective striatal neurodegeneration
33. Cloned glutamate receptors
34. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes
35. HIP1, an human homolog of S cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brain
36. Increased sensitivity to mitochondrial toxin-induced apoptosis in neuronal cells expressing mutant presenilin-1 is linked to perturbed calcium homeostasis and enhanced oxyradical production
37. Heteromultimerization and NMDA receptor-clustering activity of Chapsyn-110, a member of the PSD-95 family of proteins
38. Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay
39. Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95
40. 2+-dependent inactivation of NMDA receptors
41. Localization of alternatively spliced NMDAR1 glutamate receptor isoforms in rat striatal neurons
42. NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum
43. The changing landscape of ischaemic brain injury mechanisms
44. Enhanced sensitivity to N-methyl-D-aspartate receptor activation in transgenic and knockin mouse models of Huntington's disease
45. Huntington's disease gene (IT15) is widely expressed in human rat tissues
46. A huntingtin-associated protein enriched in brain with implications for pathology
47. Interaction of huntingtin-associated protein with dynactin P150Glued
48. The role of calcium in the regulation of apoptosis
49. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice
50. Role of the carboxy-terminal region of the GluRε2 subunit in synaptic localization of the NMDA receptor channel
51. SAP102, a novel postsynaptic protein that interacts with NMDA receptor complexes in vivo
52. Clinical aspects of CAG repeat diseases
53. Molecular mechanisms of glutamate receptor clustering at excitatory synapses
54. Mechanosensitivity of NMDA receptors in cultured mouse central neurons
55. Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models
56. Glutamate receptor ion channel properties predict vulnerability to cytotoxicity in a transfected nonneuronal cell line
57. Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA
58. The messenger RNAs for the N-methyl-D-aspartate receptor subunits show region-specific expression of different subunit composition in the human brain
59. Calcium-induced actin depolymerization reduces NMDA channel activity
60. When more is less: Pathogenesis of glutamine repeat neurodegenerative diseases
61. The QA model of Huntington's disease: Locomotor abnormalities
62. A developmental change in NMDA receptor-associated proteins at hippocampal synapses
63. Huntingtin localization in brain of normal and Huntington's-disease patients
64. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions
65. Importance of the intracellular domain of NR2 subunits for NMDA receptor function in vivo
66. HIP-1: A huntingtin interacting protein isolated by the yeast two-hybrid system
67. Toward understanding the molecular pathology of Huntington's disease
68. Competitive binding of α-actinin and calmodulin to the NMDA receptor
69. NMDA receptor losses in putamen from patients with Huntington's disease
70. Calmodulin mediates calcium-dependent inactivation of N-methyl-D-aspartate receptors